MR

Morris Rosenberg

Former EVP of Seattle Genetics at Iksuda Therapeutics

Morris participated in the development and launch of Adcetris, Avonex, Angiomax, Xigris, and Forteo. He has considerable experience in building highly successful product development teams & supervising process sciences, manufacturing, quality control, quality assurance, preclinical research, bioanalytical, and project management.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


I

Iksuda Therapeutics

1 followers

Iksuda Therapeutics is a biotechnology company specializing in the development of next generation biotherapeutics